145 related articles for article (PubMed ID: 10876184)
1. Impact of screening survey of gastric cancer on clinicopathological features and survival: retrospective study at a single institution.
Kubota H; Kotoh T; Masunaga R; Dhar DK; Shibakita M; Tachibana M; Kohno H; Nagasue N
Surgery; 2000 Jul; 128(1):41-7. PubMed ID: 10876184
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of mass screening for gastric carcinoma.
Kunisaki C; Ishino J; Nakajima S; Motohashi H; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
Ann Surg Oncol; 2006 Feb; 13(2):221-8. PubMed ID: 16411143
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of gastric cancer detected by mass screening.
Hanazaki K; Sodeyama H; Wakabayashi M; Miyazawa M; Yokoyama S; Sode Y; Kawamura N; Miyazaki T; Ohtsuka M
Hepatogastroenterology; 1997; 44(16):1126-32. PubMed ID: 9261611
[TBL] [Abstract][Full Text] [Related]
4. Decreased death from gastric cancer by endoscopic screening: association with a population-based cancer registry.
Hosokawa O; Miyanaga T; Kaizaki Y; Hattori M; Dohden K; Ohta K; Itou Y; Aoyagi H
Scand J Gastroenterol; 2008; 43(9):1112-5. PubMed ID: 18609154
[TBL] [Abstract][Full Text] [Related]
5. Effect of repeated endoscopic screening on the incidence and treatment of gastric cancer in health screenees.
Nam SY; Choi IJ; Park KW; Kim CG; Lee JY; Kook MC; Lee JS; Park SR; Lee JH; Ryu KW; Kim YW
Eur J Gastroenterol Hepatol; 2009 Aug; 21(8):855-60. PubMed ID: 19369882
[TBL] [Abstract][Full Text] [Related]
6. [Benefit of screening for gastric cancer--a comparison of symptomatic and screened patients who underwent gastrectomy].
Kobayashi O; Sugiyama Y; Konishi K; Kanari M; Cho H; Tsuburaya A; Sairenji M; Motohashi H; Yoshikawa T
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1753-8. PubMed ID: 12402425
[TBL] [Abstract][Full Text] [Related]
7. Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer.
Onodera H; Tokunaga A; Yoshiyuki T; Kiyama T; Kato S; Matsukura N; Masuda G; Tajiri T
Hepatogastroenterology; 2004; 51(55):82-5. PubMed ID: 15011835
[TBL] [Abstract][Full Text] [Related]
8. Gastric cancer: the correlation between the clinicopathological factors and patients' survival (I).
Lazăr D; Tăban S; Dema A; Cornianu M; Goldiş A; Raţiu I; Sporea I
Rom J Morphol Embryol; 2009; 50(1):41-50. PubMed ID: 19221644
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features of gastric cancer detected by endoscopy as part of annual health checkup.
Aida K; Yoshikawa H; Mochizuki C; Mori A; Muto S; Fukuda T; Otsuki M
J Gastroenterol Hepatol; 2008 Apr; 23(4):632-7. PubMed ID: 18397489
[TBL] [Abstract][Full Text] [Related]
10. The outcome of patients with remnant primary gastric cancer compared with those having upper one-third gastric cancer.
An JY; Choi MG; Noh JH; Sohn TS; Kim S
Am J Surg; 2007 Aug; 194(2):143-7. PubMed ID: 17618792
[TBL] [Abstract][Full Text] [Related]
11. Mortality from gastric cancer in patients followed with upper gastrointestinal endoscopy.
Ogura M; Hikiba Y; Maeda S; Matsumura M; Okano K; Sassa R; Yoshida H; Kawabe T; Omata M
Scand J Gastroenterol; 2008; 43(5):574-80. PubMed ID: 18415750
[TBL] [Abstract][Full Text] [Related]
12. Significance of a gastric mass screening survey.
Shiratori Y; Nakagawa S; Kikuchi A; Ishii M; Ueno M; Miyashita T; Sakurai T; Negami J; Suzuki T; Sato I
Am J Gastroenterol; 1985 Nov; 80(11):831-4. PubMed ID: 4050756
[TBL] [Abstract][Full Text] [Related]
13. Proposal to subclassify stage IV gastric cancer into IVA, IVB, and IVM.
An JY; Ha TK; Noh JH; Sohn TS; Kim S
Arch Surg; 2009 Jan; 144(1):38-45; discussion 45. PubMed ID: 19153323
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological features, surgical management, and disease outcome of perforated gastric cancer.
Jwo SC; Chien RN; Chao TC; Chen HY; Lin CY
J Surg Oncol; 2005 Sep; 91(4):219-25. PubMed ID: 16121341
[TBL] [Abstract][Full Text] [Related]
15. [End results of gastric cancer detected by mass survey: analysis using the relative survival rate curve].
Arisue T; Tamura K; Tebayashi A
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):929-36. PubMed ID: 3389836
[TBL] [Abstract][Full Text] [Related]
16. Postoperative morbidity and mortality after gastrectomy for gastric carcinoma.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 2001; 48(41):1517-20. PubMed ID: 11677999
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic prognostic factors in patients with Borrmann type 4 gastric cancer: univariate and multivariate analyses.
Yokota T; Kunii Y; Saito T; Teshima S; Narushima Y; Yamada Y; Iwamoto K; Kagami M; Takahashi M; Kikuchi S; Yamauchi H
Ups J Med Sci; 2000; 105(3):227-34. PubMed ID: 11261608
[TBL] [Abstract][Full Text] [Related]
18. Is gastric carcinoma different between Japan and the United States?
Noguchi Y; Yoshikawa T; Tsuburaya A; Motohashi H; Karpeh MS; Brennan MF
Cancer; 2000 Dec; 89(11):2237-46. PubMed ID: 11147594
[TBL] [Abstract][Full Text] [Related]
19. Results of immunochemo-surgery for gastric carcinoma.
Kim JP; Yu HJ; Lee JH
Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
[TBL] [Abstract][Full Text] [Related]
20. Mortality for gastric cancer in elderly patients.
Eguchi T; Fujii M; Takayama T
J Surg Oncol; 2003 Nov; 84(3):132-6. PubMed ID: 14598356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
